ALZHEIMER'S DISEASE: COGNITIVE MEMORY SCREENING AND REFERRAL PROGRAM
Pharmacists have a unique opportunity to identify and manage individuals with AD and other cognitive memory disorders. The Cognitive Memory Screening and Referral Program (CMSRP) is the first project to measure the impact of a pharmacist-based cognitive memory screening service delivered in community pharmacy practice in the United States. While the involvement of community pharmacists in the screening of AD is novel in the US and across the globe, there are several studies supporting community pharmacists having a significant role in screening of diseases.
- Evaluate the impact of pharmacy-based cognitive memory screening on outcomes of referral of at-risk patients to their primary care physician.
- Measure patient satisfaction with advanced clinical services and the willingness of patients to pay for cognitive memory screening services.